13223_2017_183_MOESM3_ESM.docx (23.3 kB)
MOESM3 of Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies
journal contribution
posted on 2017-04-04, 05:00 authored by Paul Ratner, Charles Andrews, Frank Hampel, Bruce Martin, Dale Mohar, Denis Bourrelly, Parisa Danaietash, Sara Mangialaio, Jasper Dingemanse, Abdel Hmissi, Jay BavelAdditional file 3: Table S1. Setipiprant trough plasma concentrations across dose groups at the end* of weeks 1 and 2 during Phase 2 and Phase 3 trials.